First Time Loading...

Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 0.79505 USD 2.19%
Updated: Mar 1, 2024

Wall Street
Price Targets

ATRA Price Targets Summary
Atara Biotherapeutics Inc

Wall Street analysts forecast ATRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATRA is 4.83 USD .

Lowest
Price Target
Not Available
Average
Price Target
4.83 USD
508% Upside
Highest
Price Target
Not Available
Atara Biotherapeutics Inc Competitors:
Price Targets
086900
Medy Tox Inc
86% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
84% Upside
IMTX
Immatics NV
50% Upside
ADCT
ADC Therapeutics SA
81% Upside
6855
Ascentage Pharma Group International
29% Upside
FOLD
Amicus Therapeutics Inc
49% Upside
TLSA
Tiziana Life Sciences Ltd
524% Upside
ORGO
Organogenesis Holdings Inc
54% Upside

Revenue
Forecast

Revenue Estimate
Atara Biotherapeutics Inc

The compound annual growth rate of Atara Biotherapeutics Inc's revenue for the next 4 years is 2%.

N/A
Past Growth
2%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Atara Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Atara Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATRA's stock price target?
Price Target
4.83 USD

According to Wall Street analysts, the average 1-year price target for ATRA is 4.83 USD .

What is Atara Biotherapeutics Inc's Revenue forecast?
Projected CAGR
2%

The compound annual growth rate of Atara Biotherapeutics Inc's revenue for the next 4 years is 2%.